PreImplantation Factor immunohistochemical expression correlates with prostate cancer aggressiveness.

Maria Rosaria RaspolliniIlaria MontagnaniPaolo CirriGianna BaroniAlessia CimadamoreMarina ScarpelliLiang ChengAntonio Lopez-BeltranRodolfo MontironiEytan R Barnea

Published in: The International journal of biological markers (2020)

Collectively, PIF assessment could be a valuable, simple-to-use immunohistochemical biomarker to evaluate aggressiveness/prognosis in specimens from prostate cancer patients.

Keyphrases

prostate cancer
radical prostatectomy
poor prognosis
binding protein
long non coding rna
benign prostatic hyperplasia
fine needle aspiration